DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zaroxolyn (Metolazone) - Gait Disturbance - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Gait Disturbance (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zaroxolyn (Metolazone) where reactions include gait disturbance. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Zaroxolyn side effects in 65 year old male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: 65 year old male, weighing 99.8 kg (219.5 pounds)

Reactions: Dyspnoea, Body Height Abnormal, Heart Rate Decreased, Micturition Disorder, Dysuria, Gait Disturbance, Blood Pressure Abnormal, Asthenia, Myocardial Infarction

Drug(s) suspected as cause:
Revatio
    Administration route: Oral
    Indication: Lung Disorder
    End date: 2012-04-11

Revatio
    Administration route: Oral
    Indication: Pulmonary Embolism
    End date: 2012-04-11

Zaroxolyn
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-03-30

Other drugs received by patient: Allopurinol; Tracleer



Possible Zaroxolyn side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-03

Patient: male, weighing 99.8 kg (219.5 pounds)

Reactions: Body Height Decreased, Dyspnoea, Cardiac Discomfort, Heart Rate Decreased, Micturition Disorder, Dysuria, Gait Disturbance, Asthenia

Drug(s) suspected as cause:
Zaroxolyn
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-03-30

Revatio
    Dosage: 20 mg, 3x/day
    Administration route: Oral
    Indication: Pulmonary Embolism
    End date: 2012-04-11

Other drugs received by patient: Allopurinol; Tracleer



Possible Zaroxolyn side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-20

Patient: male, weighing 99.8 kg (219.5 pounds)

Reactions: Body Height Decreased, Heart Rate Decreased, Dyspnoea, Cardiac Discomfort, Micturition Disorder, Dysuria, Pulmonary Oedema, Gait Disturbance, Asthenia, Cardiac Failure Congestive

Drug(s) suspected as cause:
Zaroxolyn
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-03-30

Revatio
    Dosage: 20 mg, 3x/day
    Administration route: Oral
    Indication: Pulmonary Embolism
    End date: 2012-04-11

Other drugs received by patient: Tracleer; Allopurinol

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017